Multipartite Luciferase Peptide Complexes for Sensitive Interaction Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods lack high sensitivity for detecting and monitoring molecular interactions, particularly under physiological conditions or in complex sample matrices, necessitating improved tools for bioluminescent detection.

Innovation Solution

Development of tripartite or multipartite bioluminescent complexes formed by complementary polypeptides and peptides that collectively span or have high sequence identity to a luciferase base sequence, enhancing luminescence when combined with a coelenterazine substrate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional detection methods are used, then device complexity is reduced, but measurement precision and sensitivity for detecting molecular interactions are insufficient

Engineering Contradiction:
Improvesensitivity for detecting molecular interactionsVSAvoidcomplexity of detection system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The luciferase enzyme is divided into multiple peptide fragments (e.g., N-terminal fragment, C-terminal fragment, and intermediate fragments) that can be independently produced and combined. This segmentation allows the detection system to use smaller, more manageable peptide components while maintaining the full luminescence function, thereby improving sensitivity without requiring a complete, complex enzyme system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Multiple peptide fragments are combined with a substrate (coelenterazine or analog) to form a functional bioluminescent complex. The merging of these peptide components with the substrate creates a synergistic effect that enhances luminescence signal, improving detection sensitivity while using simpler individual components rather than a single complex enzyme.

Inventive Principle:
Principle #5Merging (Combining)

2Ease of operation

If monomeric bioluminescent polypeptides are used, then ease of operation is improved, but luminescence characteristics and stability are reduced

Engineering Contradiction:
Improveease of use for detectionVSAvoidstability and luminescence characteristics
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The detection system uses multiple small peptide fragments instead of a single large monomeric polypeptide. These segmented peptides can be independently synthesized and combined with the substrate to form a functional complex, maintaining ease of operation through modular assembly while improving stability through the cooperative interaction of multiple peptide components.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The bioluminescent system is constructed as a composite of multiple peptide fragments and substrate molecules. This composite structure combines the advantages of simplicity (individual peptides are easy to handle) with enhanced stability and luminescence characteristics (the assembled complex exhibits superior properties compared to monomeric forms).

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The bioluminescent complexes exhibit significantly increased luminescence, enabling sensitive detection of molecular interactions and co-localizations, suitable for research and practical applications.

Implementation Method 1

a bioluminescent complex is formed upon the interaction of three or more peptide and/or polypeptide components... capable of generating luminescence in the presence of an appropriate substrate (e.g., a coelenterazine or a coelenterazine analog substrate)

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Data Source

PatentUS20250297961A1Multipartite luciferase peptides and polypeptides
Publication Date: 2025.09.25 PROMEGA CORP
  • US20250297961A1 patent drawing
  • US20250297961A1 patent drawing
  • US20250297961A1 patent drawing

AI summary

Provided herein are bioluminescent polypeptides and compositions and methods for the assembly of a tripartite or multipartite bioluminescent complex. In particular embodiments, a bioluminescent complex is formed upon the interaction of three or more peptide and/or polypeptide components.